Moleculin Biotech Inc (MBRX)

[TJG]

Q was put out... losses of $3.9 million but thats not above normal for a bio company that just began operation in 2015. They have made significant progress when you consider they had nothing at the start of 2015 and now have a drug headed to a Phase III trial with an Orphan Drug status.

They have over $5,000,000.00 in cash and just completed a private offering for another five million. So there is no concern for operational expenses. Some sell of because of the loss but I am not concerned about a bounce back one some weak retail gets out.